People with refractory myasthenia gravis (MG) who fail to respond to several treatments may be effectively treated with Vyvgart (efgartigimod alfa-fcab), regardless of the type of self-reactive antibodies they carry. […] The post Vyvgart may be safe, effective in treatment-resistant MG: Review appeared first on Myasthenia Gravis News.
